Solventum (NYSE:SOLV) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsAmy Wakeham - Senior Vice President of Investor Relations and External Finance CommunicationsBryan Hanson - CEODavid Roman - Managing Director in Global Investment Research DivisionDylan Finley - Director in Equity ResearchRick Wise - Managing Director in Medical Technology and SuppliesTravis Steed - Director in Medical Technology Equity ResearchVik Chopra - Director in Medical Technology Equity ResearchWayde McMil ...

Solventum (NYSE:SOLV) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsAmy Wakeham - Senior Vice President of Investor Relations and External Finance CommunicationsBryan Hanson - CEODavid Roman - Managing Director in Global Investment Research DivisionDylan Finley - Director in Equity ResearchLeah Keiser - Equity Research AssociateRick Wise - Managing Director in Medical Technology and SuppliesTravis Steed - Director in Medical Technology Equity ResearchWayde McMillan - CFOConference ...

Solventum (NYSE:SOLV) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Speaker6Good afternoon. My name is Audra, and I will be your conference call operator today. I would like to welcome everyone to Solventum's fourth quarter 2025 earnings call. As a reminder, this conference is being recorded. All lines have been placed on mute to prevent any background noise. I would now like to turn the program over to your host for today's conference, Amy Wakeham, Senior Vice President of Investor Relations and Fina ...